TNA Therapeutics
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.tnatherapeutics.comRevenue
<$5 MillionIndustry
About TNA Therapeutics
TNA Therapeutics is an early-stage pharmaceutical company focused on developing TNAT-101, a first-in-class oral agent that targets BCL3 to treat rare and difficult-to-treat cancers. The company aims to provide significant patient benefits by developing innovative small molecule inhibitors that not only induce tumor regressions but also prevent metastasis. With a strong emphasis on targeting cancer stem cells, TNA Therapeutics seeks to improve overall survival rates in patients. The company is committed to growth through partnerships and collaborations in the oncology field.Explore more
TNA Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to TNA Therapeutics
Compare insights from companies similar to TNA Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TNA Therapeutics Tech Stack
A closer look at the technologies used by TNA Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TNA Therapeutics
Sign Up For FreeTo access detailed company insights
TNA Therapeutics is an early-stage pharmaceutical company focused on developing TNAT-101, a first-in-class oral agent that targets BCL3 to treat rare and difficult-to-treat cancers. The company aims to provide significant patient benefits by developing innovative small molecule inhibitors that not only induce tumor regressions but also prevent meta... Read More
